Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Wall Street futures declined on Friday, hammered by new U.S. tariffs on dozens of trading partners and Amazon's unimpressive earnings, while investors awaited a key jobs report to gauge the Federal Reserve's next move. .N
** Novo Nordisk A/S <NVO.N>:
** AstraZeneca PLC <AZN.O>:
** Sanofi SA <SNY.O>:
** GSK PLC <GSK.N>:BUZZ - European pharma falls after Trump ramps up pressure to cut US drug prices nL6N3TT09S
** Reddit Inc <RDDT.N>:BUZZ - Shares light up premarket after blowout Q3 outlook nL4N3TT0N3
** Chevron Corp <CVX.N>:BUZZ - Gains on Q2 profit beat nL4N3TT0S7
** Roku Inc <ROKU.O>:BUZZ - Dips despite beating Q2 estimates nL6N3TT0CZ
** Figma Inc <FIG.N>:BUZZ - Extends gains after stellar public debut nL6N3TT0EC
** Eastman Chemical Co <EMN.N>:BUZZ - Falls on downbeat Q3 profit expectations nL4N3TT0PB
** Eli Lilly and Co <LLY.N>:BUZZ - Rises on report of Medicare, Medicaid coverage for weight-loss drugs nL4N3TT0W4
** Exxon Mobil Corp <XOM.N>:BUZZ - Gains after Q2 profit beat nL4N3TT0SL
** Kimberly-Clark Corp <KMB.O>:BUZZ - Rises on upbeat Q2 results nL6N3TT0FV
** Moderna Inc <MRNA.O>:BUZZ - Falls after lowering 2025 sales forecast nL4N3TT0ZF
** Hims & Hers Health Inc <HIMS.N>:BUZZ - Slips on report of Medicare, Medicaid coverage for weight-loss drugs nL4N3TT105
(Rajarshi Roy and Parth Chandna)
((Rajarshi.Roy@thomsonreuters.com and Parth.Chandna@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.